Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 109/L to <100 × 109/L) at baseline: the final analysis of EXPAND
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.